Reaction
Atrioventricular Septal Defect reporting signals
As of the last recalculation, Atrioventricular Septal Defect appears in 469 FAERS reports alongside 14 co-occurring drug terms. The strongest observed disproportionality signal is NEVIRAPINE (PRR 108.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Nevirapine | 21 | 108.1 | 108.4 |
| Abacavir Sulfate | 22 | 105.1 | 105.3 |
| Darunavir | 32 | 100.7 | 100.9 |
| Labetalol | 22 | 76.8 | 76.9 |
| Ritonavir 100 Mg | 24 | 75.1 | 75.2 |
| Ritonavir | 38 | 62.7 | 62.8 |
| Lamivudine Oral | 26 | 48.2 | 48.3 |
| Zidovudine | 12 | 40.8 | 40.9 |
| Lamivudine | 26 | 39.5 | 39.5 |
| Botulinum Toxin Type A | 10 | 36.5 | 36.5 |
| Lopinavir And Ritonavir | 8 | 26.6 | 26.6 |
| Emtricitabine And Tenofovir Disoproxil Fumarate | 22 | 22.4 | 22.4 |
| Palivizumab | 6 | 17.5 | 17.6 |
| Erenumab-Aooe | 9 | 7.4 | 7.4 |